Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Early research (Phase 1)Study completedNCT03357939
What this trial is testing

Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

Who this might be right for
Immune System Disorder
Shanghai Henlius Biotech 220
Early research (Phase 1)Study completedNCT06474377
What this trial is testing

Clinical Trial of PCV24 in Adults

Who this might be right for
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd. 170
Early research (Phase 1)Active Not RecruitingNCT07289503
What this trial is testing

Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Who this might be right for
Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT02746783
What this trial is testing

Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients

Who this might be right for
Healthy Volunteers
University of Lausanne Hospitals 163
Large-scale testing (Phase 3)Active Not RecruitingNCT06007183
What this trial is testing

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination

Who this might be right for
Chikungunya Virus Infection
Bavarian Nordic 715
Early research (Phase 1)Study completedNCT03287310
What this trial is testing

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Who this might be right for
Asthma
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT01451086
What this trial is testing

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China

Who this might be right for
Healthy
Jiangsu Province Centers for Disease Control and Prevention 1,200
Testing effectiveness (Phase 2)Study completedNCT02140762
What this trial is testing

Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 305
Large-scale testing (Phase 3)Study completedNCT00197288
What this trial is testing

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

Who this might be right for
Influenza
GlaxoSmithKline 1,847
Testing effectiveness (Phase 2)Study completedNCT02775942
What this trial is testing

Safety and Immunogenicity of IPOVAC in Young Children

Who this might be right for
Poliomyelitis
National Institute of Hygiene and Epidemiology, Vietnam 240
Early research (Phase 1)Study completedNCT03844386
What this trial is testing

Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 26
Testing effectiveness (Phase 2)WithdrawnNCT03191383
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT01064141
What this trial is testing

Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi 210
Large-scale testing (Phase 3)Study completedNCT05089123
What this trial is testing

The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 320
Testing effectiveness (Phase 2)Study completedNCT00329927
What this trial is testing

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Who this might be right for
Influenza
Novartis 60
Early research (Phase 1)Study completedNCT00106769
What this trial is testing

Vaccine to Prevent West Nile Virus Disease

Who this might be right for
HealthyWest Nile FeverHealthy Volunteer+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)Study completedNCT01776554
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 662
Testing effectiveness (Phase 2)Study completedNCT00584805
What this trial is testing

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine

Who this might be right for
Eastern Equine Encephalitis
U.S. Army Medical Research and Development Command 138
Testing effectiveness (Phase 2)Study completedNCT01775462
What this trial is testing

Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Who this might be right for
X-Linked Hypohidrotic Ectodermal Dysplasia
Edimer Pharmaceuticals 6
Next Page